Review
Open access
2026
: Acute myeloid leukemia (AML) is driven by dysregulated transcription factors (TFs) that disrupt hematopoietic differentiation, promote leukemic self-renewal, and confer therapy resistance. Key TFs including C/EBP α , PU.1, RUNX1, GATA2, EVI1, PML-RAR α fusion protein, p53, c-Myc and ERG are altered through mutations,...
Annisa Nurul Ilmi, Rudy Agung Nugroho, Sendy Junedi et al.
· Oncology Research · 0 citations